Search

The COVID-19 pandemic has impacted university faculty in profound ways, particularly those who are marginalized by gender. While social and institutional injustices have always existed for these faculty, stressors related to caregiving during a global pandemic have exacerbated inequities related to distribution of care work at home and teaching and caring for students. This amplification of inequities has affected the health and well-being of gender-marginalized faculty, as well as their professional careers. The multi-method qualitative research study described in this report, through a survey and follow-up interviews, examined the impact of caregiving on gender-marginalized faculty at Brandon University during the COVID-19 pandemic. Findings from the study illustrate the problematic nature of caregiving for faculty marginalized by gender, the toll it has taken during a global crisis, and the imperative to equitably recognize, value, and compensate such work.

Background: There is a clinical need for treatments that can slow or prevent the growth of an abdominal aortic aneurysm, not only to reduce the need for surgery, but to provide a means to treat those who cannot undergo surgery. Methods: Analysis of the UK Aneurysm Growth Study (UKAGS) prospective cohort was conducted to test for an association between cardiometabolic medications and the growth of an abdominal aortic aneurysm above 30 mm in diameter, using linear mixed-effect models. Results: A total of 3670 male participants with data available on abdominal aortic aneurysm growth, smoking status, co-morbidities, and medication history were included. The mean age at recruitment was 69.5 years, the median number of surveillance scans was 6, and the mean(s.e.) unadjusted abdominal aortic aneurysm growth rate was 1.75(0.03) mm/year. In a multivariate linear mixed-effect model, smoking (mean(s.e.) +0.305(0.07) mm/year, P = 0.00003) and antiplatelet use (mean(s.e.) +0.235(0.06) mm/year, P = 0.00018) were found to be associated with more rapid abdominal aortic aneurysm growth, whilst metformin was strongly associated with slower abdominal aortic aneurysm growth (mean(s.e.) −0.38(0.1) mm/year, P = 0.00019), as were angiotensin-converting enzyme inhibitors (mean(s.e.) −0.243(0.07) mm/year, P = 0.0004), angiotensin II receptor antagonists (mean(s.e.) −0.253(0.08) mm/year, P = 0.00255), and thiazides/related diuretics (mean(s.e.) −0.307(0.09) mm/year, P = 0.00078). Conclusion: The strong association of metformin with slower abdominal aortic aneurysm growth highlights the importance of the ongoing clinical trials assessing the effectiveness of metformin with regard to the prevention of abdominal aortic aneurysm growth and/or rupture. The association of angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and diuretics with slower abdominal aortic aneurysm growth points to the possibility that optimization of cardiovascular risk management as part of abdominal aortic aneurysm surveillance may have the secondary benefit of also reducing abdominal aortic aneurysm growth rates. Abdominal aortic aneurysm growth rates were compared with smoking status, co-morbidities, and medication history in the UK Aneurysm Growth Study (UKAGS) prospective cohort. It was found that: smoking and antiplatelet use were associated with a more rapid abdominal aortic aneurysm growth rate; the drug metformin was strongly associated with a slower abdominal aortic aneurysm growth rate; and drugs in the angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist, and thiazide/related diuretic classes were also associated with a slower abdominal aortic aneurysm growth rate. These results suggest that common cardiometabolic medications may be useful therapeutic options to slow abdominal aortic aneurysm growth rates. [ABSTRACT FROM AUTHOR]

Considering how Hamburg-Wilhelmsburg has been stigmatized for decades, and recently targeted for redevelopment, you would hardly guess from the outside that the neighborhood is beloved by racialized long-time residents, and considered to be a warm, welcoming Heimat: a space of belonging, where you do not have to justify your presence. This identification is tied to the neighborhood's racialization; the qualities that have been labeled as problems to be transformed through social mix make it a space of relative safety and security, in a context in which many residents experience attempted exclusions from German identity. Based on interviews with racialized long-time residents, contextualized within racialization in Germany, the racialized displaceability embedded in social mix policy, the contested meaning of Heimat, and the experiences of Wilhelmsburg residents with migrantization, I argue that this emphatic claim is a strength that is threatened by the current process of social mix gentrification. [ABSTRACT FROM AUTHOR]